Skip to main content
HOWL
NASDAQ Life Sciences

Werewolf Q3: $41.9M Cash, Going Concern, Dec 17 Merger Vote

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.984
Mkt Cap
$47.642M
52W Low
$0.27
52W High
$1.2
52W Position info
264% above low
Off High info
18% below high
Rel. Volume
Market data snapshot near publication time

HOWL has more than doubled off its 52-week low of $0.27.

Summary

Werewolf closed Q3 with $41.9 million in cash but reiterated going-concern doubt, with its survival tied to the Ambros reverse merger and a December 17, 2026 stockholder vote.


Key Events · Earnings and Guidance · HOWL

  • Q3 Cash Position and Going Concern

    Cash and cash equivalents reached $41.9 million at September 30, 2026, up from the $22 million cited in the prior quarterly baseline, yet the filing states substantial doubt about continuing as a going concern for at least twelve months.

  • Nine-Month Loss Narrows Sharply

    The net loss was $19.7 million for the nine months ended September 30, 2026, versus $52.4 million a year earlier, helped by $21.0 million of collaboration revenue from the Jazz asset sale and deep cost cuts.

  • Term Loan Repaid in Full

    Repayment of the K2HV term loan on May 6, 2026 cost $31.4 million and produced a $3.4 million loss on extinguishment; no interest expense was recorded in Q3 2026.

  • EMD Proceeds Held as Deferred Income

    The EMD asset sale carries a $33.9 million transaction price ($28.0 million upfront, $0.9 million reimbursement, $5.0 million on technology transfer); $28.85 million received to date sits in deferred income and is expected to be recognized in Q4 2026 on acceptance.


Analysis · HOWL · Life Sciences

Cash stood at $41.9 million on September 30, up from the $22 million cited in the prior quarterly baseline, lifted by the $21.0 million Jazz payment and $28.9 million received from EMD; the K2HV term loan was also repaid in full for $31.4 million. Even so, management flags substantial doubt about the company's ability to continue as a going concern for at least twelve months, and survival hinges on closing the Ambros reverse merger on time. The Form S-4 was declared effective November 12 and the stockholder vote is set for December 17, 2026; should the deal fail, the board may pursue another transaction or a dissolution and liquidation. Meanwhile, the EMD sale's $33.9 million transaction price remains in deferred income pending acceptance, expected in Q4 2026.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, HOWL was trading at $0.98 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $47.6M. The 52-week trading range was $0.27 to $1.20. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HOWL - Latest Insights

HOWL
Nov 10, 2026, 4:37 PM EST
Filing Type: S-4/A
Importance Score:
8
Price at Filing: $0.970
Real-time Price: $0.9836 info
Change: +$0.0136 (+1%) info
Market Cap: $47.642M info
HOWL
Nov 09, 2026, 9:22 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.00
Real-time Price: $0.9836 info
Change: -$0.0164 (-2%) info
Market Cap: $47.642M info
HOWL
Oct 26, 2026, 5:23 PM EDT
Filing Type: S-4/A
Importance Score:
8
Price at Filing: $0.9806
Real-time Price: $0.9836 info
Change: +$0.0030 (+0.31%) info
Market Cap: $47.642M info
HOWL
Sep 22, 2026, 5:04 PM EDT
Filing Type: S-4
Importance Score:
9
Price at Filing: $0.9707
Real-time Price: $0.9836 info
Change: +$0.0129 (+1%) info
Market Cap: $47.642M info
HOWL
Aug 21, 2026, 9:12 AM EDT
Filing Type: 425
Importance Score:
9
Price at Filing: $1.04
Real-time Price: $0.9836 info
Change: -$0.0579 (-6%) info
Market Cap: $47.642M info